Clinical Trials Logo

Episodic Cluster Headache clinical trials

View clinical trials related to Episodic Cluster Headache.

Filter by:
  • None
  • Page 1

NCT ID: NCT02945046 Terminated - Clinical trials for Episodic Cluster Headache

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Start date: January 19, 2017
Phase: Phase 3
Study type: Interventional

This is a 13-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study to compare the efficacy and safety of 2 dose regimens of TEV-48125 (Fremanezumab) versus placebo in adult participants for the prevention of ECH.

NCT ID: NCT02797951 Completed - Clinical trials for Chronic Cluster Headache

A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

Start date: July 13, 2016
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to assess the long-term safety and tolerability of galcanezumab administered up to once monthly in participants with episodic or chronic cluster headache who have completed study I5Q-MC-CGAL (NCT02397473) or study I5Q-MC-CGAM (NCT02438826).

NCT ID: NCT02397473 Completed - Clinical trials for Episodic Cluster Headache

A Study Of Galcanezumab In Participants With Episodic Cluster Headache

Start date: May 22, 2015
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as Galcanezumab in participants with episodic cluster headaches.

NCT ID: NCT02209155 Terminated - Clinical trials for Episodic Cluster Headache

R-Verapamil for the Prophylaxis of Episodic Cluster Headache

Start date: November 2013
Phase: Phase 2
Study type: Interventional

This is a double-blinded, randomized, parallel, placebo-controlled phase 2 study to evaluate the safety and efficacy of R-verapamil in the prophylaxis of episodic cluster headache.

NCT ID: NCT01341548 Not yet recruiting - Clinical trials for Episodic Cluster Headache

Civamide Nasal Solution for Cluster Headache

ECH
Start date: November 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of intranasally administered civamide nasal solution in the prevention of cluster headaches during an episodic cluster headache period.

NCT ID: NCT00399243 Unknown status - Clinical trials for Chronic Cluster Headache

Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache

Start date: November 2006
Phase: Phase 4
Study type: Interventional

This study's hypothesis is the 4mg StatDose sumatriptan is effective for the acute treatment of cluster headache and provides good safety and tolerability across multiple doses of the study medication as well as across multiple attacks of cluster headache. This study seeks to determine the safety and efficacy of the commercially available 4mg StatDose formulation of sumatriptan as an acute treatment of cluster headache. Patients are allowed to use repeated dose of the study medication for a given headache if they have had a partial response to the first dose. They may treat up to 3 attacks of cluster headache with the study medication. Safety assessment will be through adverse event reporting and physical examination. Patients with both episodic cluster headache as well as chronic cluster headache will be studied. Patients must either not have started preventive treatment for cluster headache or be on a stable dose of preventive medication.

NCT ID: NCT00069082 Completed - Clinical trials for Episodic Cluster Headache

Intranasal Civamide for Episodic Cluster Headache

Start date: August 2003
Phase: Phase 3
Study type: Interventional

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

NCT ID: NCT00033839 Completed - Clinical trials for Episodic Cluster Headache

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

Start date: January 2002
Phase: Phase 3
Study type: Interventional

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).